HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

HSBA

1,445.6

+0.54%↑

BARC

517

+1%↑

LLOY

109.6

+1.11%↑

STAN

2,055

+0.05%↑

FERG.UK

18,000

+1.24%↑

Search

ConvaTec Group PLC

Avatud

SektorRahandus

210.4 3.34

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

204

Max

210.8

Põhinäitajad

By Trading Economics

Sissetulek

-34M

71M

Müük

85M

1.3B

P/E

Sektori keskmine

29.8

22.989

Aktsiakasum

0.08

Dividenditootlus

3.47

Kasumimarginaal

5.575

Töötajad

10,910

EBITDA

57M

338M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+44.01% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

3.47%

4.69%

Järgmine tulemuste avaldamine

4. aug 2026

Järgmine aktsia dividendi kuupäev (ex-date)

20. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-793M

4.1B

Eelmine avamishind

207.06

Eelmine sulgemishind

210.4

Uudiste sentiment

By Acuity

50%

50%

157 / 439 Pingereas Finance

ConvaTec Group PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Ettevõttest ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat